Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mybl2
|
ENSMUSG00000017861.5 | myeloblastosis oncogene-like 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_163054662_163055903 | Mybl2 | 595 | 0.635621 | 0.59 | 5.8e-07 | Click! |
chr2_163056550_163056708 | Mybl2 | 1942 | 0.227188 | 0.39 | 2.2e-03 | Click! |
chr2_163048212_163048474 | Mybl2 | 6344 | 0.130147 | 0.37 | 3.4e-03 | Click! |
chr2_163059352_163059507 | Mybl2 | 80 | 0.954290 | 0.30 | 2.1e-02 | Click! |
chr2_163056719_163056923 | Mybl2 | 2134 | 0.210475 | 0.23 | 7.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_44015370_44016774 | 13.17 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr9_89879614_89881129 | 10.89 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
29537 |
0.16 |
chr9_111055888_111057545 | 7.43 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chrX_143825863_143827628 | 7.41 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr11_78072614_78073453 | 6.95 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr10_117046957_117047576 | 6.59 |
Lrrc10 |
leucine rich repeat containing 10 |
1925 |
0.23 |
chr7_25626920_25628374 | 6.56 |
B3gnt8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
5 |
0.94 |
chr10_115817324_115818606 | 6.45 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr10_77112255_77113959 | 6.18 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
chr9_48338929_48340200 | 6.17 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr2_91949326_91950727 | 6.15 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr2_158145151_158146425 | 5.75 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr5_103755393_103755691 | 5.53 |
Aff1 |
AF4/FMR2 family, member 1 |
969 |
0.6 |
chr9_103180449_103181154 | 5.34 |
Srprb |
signal recognition particle receptor, B subunit |
11511 |
0.16 |
chr18_67288221_67288463 | 5.30 |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
844 |
0.56 |
chr9_108340445_108340596 | 5.28 |
Gpx1 |
glutathione peroxidase 1 |
1244 |
0.21 |
chr10_127749619_127751660 | 5.26 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr14_63268302_63270010 | 5.16 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr8_104101710_104103631 | 5.13 |
Cdh5 |
cadherin 5 |
1045 |
0.43 |
chr4_139336568_139337223 | 5.08 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
285 |
0.73 |
chr18_84858127_84859558 | 5.07 |
Gm16146 |
predicted gene 16146 |
705 |
0.62 |
chr2_32608081_32609404 | 5.03 |
St6galnac6 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
25 |
0.94 |
chr19_5724785_5726881 | 4.99 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr11_78984345_78985263 | 4.95 |
Lgals9 |
lectin, galactose binding, soluble 9 |
27 |
0.98 |
chr11_109860046_109860775 | 4.94 |
1700023C21Rik |
RIKEN cDNA 1700023C21 gene |
14532 |
0.18 |
chr12_105034788_105035573 | 4.94 |
Glrx5 |
glutaredoxin 5 |
36 |
0.95 |
chr16_38371842_38372227 | 4.93 |
Popdc2 |
popeye domain containing 2 |
36 |
0.96 |
chr9_21759558_21760262 | 4.88 |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
372 |
0.78 |
chr4_11705100_11705674 | 4.87 |
Gem |
GTP binding protein (gene overexpressed in skeletal muscle) |
420 |
0.85 |
chr13_106691708_106691940 | 4.83 |
Gm30411 |
predicted gene, 30411 |
69755 |
0.09 |
chr8_80868770_80869328 | 4.80 |
Gm31105 |
predicted gene, 31105 |
10891 |
0.18 |
chr14_79535326_79536502 | 4.78 |
Elf1 |
E74-like factor 1 |
20216 |
0.14 |
chr11_87663976_87665005 | 4.68 |
Rnf43 |
ring finger protein 43 |
59 |
0.96 |
chr9_92276388_92276986 | 4.66 |
Plscr2 |
phospholipid scramblase 2 |
941 |
0.48 |
chr19_32107415_32107757 | 4.58 |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
563 |
0.82 |
chr11_49251965_49252173 | 4.57 |
Mgat1 |
mannoside acetylglucosaminyltransferase 1 |
1479 |
0.28 |
chr2_167690537_167691384 | 4.56 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
217 |
0.84 |
chrX_9275213_9275657 | 4.53 |
Xk |
X-linked Kx blood group |
2679 |
0.18 |
chr5_98028089_98028741 | 4.51 |
Antxr2 |
anthrax toxin receptor 2 |
2547 |
0.22 |
chr16_38364563_38365451 | 4.50 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr5_137570868_137571950 | 4.47 |
Tfr2 |
transferrin receptor 2 |
42 |
0.93 |
chr19_58413288_58413588 | 4.45 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
41028 |
0.17 |
chr13_109687562_109688031 | 4.44 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1620 |
0.56 |
chr18_60500309_60500522 | 4.43 |
Smim3 |
small integral membrane protein 3 |
1161 |
0.44 |
chr3_128990459_128991248 | 4.36 |
Gm9387 |
predicted pseudogene 9387 |
35755 |
0.19 |
chr2_180724979_180726144 | 4.29 |
Slc17a9 |
solute carrier family 17, member 9 |
161 |
0.92 |
chr7_113295089_113296008 | 4.24 |
Gm45355 |
predicted gene 45355 |
211 |
0.93 |
chr5_36621046_36621447 | 4.22 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
9 |
0.96 |
chr17_25077528_25081106 | 4.18 |
Tmem204 |
transmembrane protein 204 |
1093 |
0.35 |
chr11_5802324_5803834 | 4.18 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr10_94919501_94920004 | 4.13 |
Plxnc1 |
plexin C1 |
2905 |
0.28 |
chr11_103027810_103028268 | 4.12 |
Nmt1 |
N-myristoyltransferase 1 |
151 |
0.59 |
chr6_34383998_34385217 | 4.12 |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
326 |
0.82 |
chr1_133800027_133801076 | 4.11 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
485 |
0.75 |
chr14_79516555_79517268 | 4.09 |
Elf1 |
E74-like factor 1 |
1213 |
0.43 |
chr13_42050767_42051005 | 4.07 |
Hivep1 |
human immunodeficiency virus type I enhancer binding protein 1 |
1135 |
0.45 |
chr3_84189998_84191469 | 4.04 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr11_120437779_120437964 | 4.00 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
163 |
0.87 |
chr5_21543417_21545108 | 3.99 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr10_121476493_121476876 | 3.97 |
Rassf3 |
Ras association (RalGDS/AF-6) domain family member 3 |
337 |
0.81 |
chr1_177494861_177495402 | 3.97 |
Gm37306 |
predicted gene, 37306 |
27753 |
0.14 |
chr6_136875262_136875841 | 3.97 |
Mgp |
matrix Gla protein |
230 |
0.87 |
chr16_75343494_75343690 | 3.96 |
Gm49677 |
predicted gene, 49677 |
55682 |
0.15 |
chr15_78571734_78572724 | 3.88 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chr7_19290671_19291896 | 3.85 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr8_122546551_122549259 | 3.82 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr19_47319497_47320713 | 3.79 |
Sh3pxd2a |
SH3 and PX domains 2A |
5354 |
0.2 |
chr16_57551320_57551493 | 3.79 |
Filip1l |
filamin A interacting protein 1-like |
2164 |
0.39 |
chr4_139330799_139331477 | 3.74 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
6042 |
0.09 |
chr2_119048087_119048279 | 3.74 |
Knl1 |
kinetochore scaffold 1 |
1033 |
0.41 |
chrX_143824621_143825251 | 3.73 |
Capn6 |
calpain 6 |
2396 |
0.29 |
chr9_44340460_44342952 | 3.72 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr18_11049995_11051717 | 3.71 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr11_85799424_85800600 | 3.71 |
Bcas3 |
breast carcinoma amplified sequence 3 |
1809 |
0.24 |
chrX_19166017_19167833 | 3.68 |
Gm14636 |
predicted gene 14636 |
307 |
0.9 |
chr5_64599895_64600712 | 3.68 |
Gm3716 |
predicted gene 3716 |
2857 |
0.18 |
chr10_7472533_7472784 | 3.65 |
Ulbp1 |
UL16 binding protein 1 |
683 |
0.71 |
chr11_21369138_21369449 | 3.61 |
Gm12043 |
predicted gene 12043 |
1107 |
0.33 |
chr14_31576784_31577279 | 3.61 |
Colq |
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
352 |
0.85 |
chr8_25720911_25721176 | 3.61 |
Plpp5 |
phospholipid phosphatase 5 |
455 |
0.68 |
chr1_37478065_37479166 | 3.60 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr9_57158351_57158614 | 3.59 |
Commd4 |
COMM domain containing 4 |
151 |
0.93 |
chr8_94985246_94986199 | 3.58 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr7_5060529_5061652 | 3.58 |
Gm45133 |
predicted gene 45133 |
959 |
0.21 |
chr4_94739067_94739954 | 3.58 |
Tek |
TEK receptor tyrosine kinase |
8 |
0.98 |
chr14_76532606_76533942 | 3.54 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr8_91966975_91968067 | 3.54 |
Gm36670 |
predicted gene, 36670 |
24348 |
0.14 |
chr11_90676738_90677124 | 3.51 |
Tom1l1 |
target of myb1-like 1 (chicken) |
10648 |
0.2 |
chr3_128520016_128520866 | 3.51 |
Gm22293 |
predicted gene, 22293 |
19931 |
0.25 |
chr7_100492685_100494805 | 3.49 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr16_75907897_75908072 | 3.49 |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
1295 |
0.55 |
chr3_96450951_96451691 | 3.48 |
Gm26232 |
predicted gene, 26232 |
875 |
0.23 |
chr3_10207495_10207881 | 3.48 |
Fabp4 |
fatty acid binding protein 4, adipocyte |
870 |
0.42 |
chr15_33082896_33084013 | 3.42 |
Cpq |
carboxypeptidase Q |
186 |
0.96 |
chr17_28007198_28009699 | 3.41 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr17_71019478_71020561 | 3.39 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr11_100735674_100736591 | 3.39 |
Rab5c |
RAB5C, member RAS oncogene family |
2044 |
0.17 |
chr12_24708730_24709261 | 3.39 |
Rrm2 |
ribonucleotide reductase M2 |
34 |
0.97 |
chr1_74390490_74390672 | 3.38 |
Ctdsp1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
928 |
0.38 |
chr3_102165384_102165916 | 3.35 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
chr7_45920062_45921322 | 3.34 |
Emp3 |
epithelial membrane protein 3 |
159 |
0.87 |
chr4_11146992_11147797 | 3.33 |
Gm11830 |
predicted gene 11830 |
2684 |
0.17 |
chr7_49450183_49451616 | 3.33 |
Nav2 |
neuron navigator 2 |
139 |
0.97 |
chr2_76980010_76980504 | 3.32 |
Ttn |
titin |
75 |
0.98 |
chr3_84154730_84155172 | 3.32 |
Mnd1 |
meiotic nuclear divisions 1 |
835 |
0.63 |
chr12_105012986_105013545 | 3.31 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
3456 |
0.13 |
chr4_43507951_43509367 | 3.31 |
Gm12454 |
predicted gene 12454 |
65 |
0.55 |
chr2_163396823_163398215 | 3.30 |
Jph2 |
junctophilin 2 |
430 |
0.77 |
chr10_84577742_84578017 | 3.29 |
Tcp11l2 |
t-complex 11 (mouse) like 2 |
982 |
0.44 |
chr5_122145241_122145905 | 3.29 |
Ccdc63 |
coiled-coil domain containing 63 |
4750 |
0.15 |
chr4_66828210_66828477 | 3.28 |
Tlr4 |
toll-like receptor 4 |
141 |
0.98 |
chr2_24387080_24387441 | 3.27 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
643 |
0.66 |
chr2_166564465_166564704 | 3.27 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
8393 |
0.22 |
chr6_144822659_144823226 | 3.27 |
Gm22792 |
predicted gene, 22792 |
19310 |
0.19 |
chr3_152261831_152262449 | 3.25 |
Nexn |
nexilin |
390 |
0.79 |
chr12_117657998_117660727 | 3.25 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr2_75776376_75777638 | 3.24 |
Gm13657 |
predicted gene 13657 |
181 |
0.93 |
chr16_58674023_58674421 | 3.24 |
Cpox |
coproporphyrinogen oxidase |
86 |
0.96 |
chr14_67713810_67713961 | 3.22 |
Cdca2 |
cell division cycle associated 2 |
1490 |
0.31 |
chr3_69007125_69007593 | 3.22 |
Smc4 |
structural maintenance of chromosomes 4 |
2344 |
0.15 |
chr14_51062924_51063458 | 3.20 |
Rnase12 |
ribonuclease, RNase A family, 12 (non-active) |
5530 |
0.09 |
chr10_8878382_8878908 | 3.20 |
Gm26674 |
predicted gene, 26674 |
5992 |
0.16 |
chr16_91466275_91466861 | 3.20 |
Gm49626 |
predicted gene, 49626 |
1443 |
0.19 |
chr4_106804374_106805428 | 3.19 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr8_119345227_119345501 | 3.18 |
Hsbp1 |
heat shock factor binding protein 1 |
119 |
0.96 |
chr1_40805583_40806390 | 3.16 |
Tmem182 |
transmembrane protein 182 |
385 |
0.84 |
chr2_158144210_158144729 | 3.15 |
Tgm2 |
transglutaminase 2, C polypeptide |
1897 |
0.28 |
chr5_90224689_90224840 | 3.15 |
Cox18 |
cytochrome c oxidase assembly protein 18 |
763 |
0.69 |
chr14_63123716_63123867 | 3.14 |
Ctsb |
cathepsin B |
1277 |
0.35 |
chr3_142883282_142883474 | 3.14 |
9530052C20Rik |
RIKEN cDNA 9530052C20 gene |
883 |
0.39 |
chr1_176836732_176837286 | 3.14 |
Gm38158 |
predicted gene, 38158 |
1285 |
0.31 |
chr4_32170638_32171072 | 3.13 |
Gm11928 |
predicted gene 11928 |
21069 |
0.18 |
chr13_5714127_5714791 | 3.12 |
Gm35330 |
predicted gene, 35330 |
9983 |
0.27 |
chr1_135840170_135841177 | 3.12 |
Tnnt2 |
troponin T2, cardiac |
26 |
0.97 |
chr7_127137544_127138135 | 3.11 |
Spn |
sialophorin |
16 |
0.94 |
chr5_102724663_102726037 | 3.11 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr3_127791213_127791364 | 3.10 |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
484 |
0.69 |
chr5_103759804_103761265 | 3.10 |
Aff1 |
AF4/FMR2 family, member 1 |
5961 |
0.23 |
chr11_86755021_86755531 | 3.09 |
Cltc |
clathrin, heavy polypeptide (Hc) |
2225 |
0.31 |
chr1_160306832_160307632 | 3.09 |
Rabgap1l |
RAB GTPase activating protein 1-like |
107 |
0.95 |
chr17_71182921_71183437 | 3.09 |
Lpin2 |
lipin 2 |
377 |
0.84 |
chr4_11192780_11193219 | 3.08 |
Ccne2 |
cyclin E2 |
402 |
0.79 |
chr11_97434598_97436859 | 3.08 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr6_136857054_136858156 | 3.06 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr3_122104159_122104612 | 3.06 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
15655 |
0.16 |
chr4_134865242_134865477 | 3.06 |
Rhd |
Rh blood group, D antigen |
823 |
0.59 |
chr9_56416072_56416694 | 3.04 |
Gm36940 |
predicted gene, 36940 |
317 |
0.81 |
chr6_72388069_72388633 | 3.04 |
Vamp8 |
vesicle-associated membrane protein 8 |
1560 |
0.22 |
chr3_135826999_135827214 | 3.03 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
1016 |
0.49 |
chr14_45526681_45527537 | 3.03 |
Fermt2 |
fermitin family member 2 |
2677 |
0.14 |
chr1_138618205_138618747 | 3.03 |
Nek7 |
NIMA (never in mitosis gene a)-related expressed kinase 7 |
1198 |
0.48 |
chr19_20389423_20390852 | 3.02 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr19_42519590_42519741 | 3.01 |
R3hcc1l |
R3H domain and coiled-coil containing 1 like |
843 |
0.64 |
chr3_154091887_154092343 | 3.01 |
Gm3076 |
predicted gene 3076 |
40225 |
0.13 |
chr17_32402642_32402967 | 3.00 |
A530088E08Rik |
RIKEN cDNA A530088E08 gene |
202 |
0.81 |
chr7_4629257_4630354 | 3.00 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr9_85324630_85325846 | 3.00 |
Tent5a |
terminal nucleotidyltransferase 5A |
1886 |
0.28 |
chr17_34983026_34983177 | 2.99 |
Lsm2 |
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated |
892 |
0.22 |
chr6_94729909_94730132 | 2.96 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
29862 |
0.17 |
chr7_143054702_143054948 | 2.96 |
R74862 |
expressed sequence R74862 |
1139 |
0.3 |
chr8_126056070_126056237 | 2.96 |
Gm45876 |
predicted gene 45876 |
4371 |
0.23 |
chr17_28823777_28824059 | 2.94 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
108 |
0.92 |
chr12_34713492_34714861 | 2.92 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr11_78194258_78195234 | 2.92 |
Proca1 |
protein interacting with cyclin A1 |
0 |
0.93 |
chr13_49608239_49608629 | 2.91 |
Ogn |
osteoglycin |
388 |
0.81 |
chr6_35254006_35254157 | 2.91 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
1349 |
0.37 |
chr5_137290070_137291279 | 2.91 |
Ache |
acetylcholinesterase |
1427 |
0.17 |
chr4_134252565_134254419 | 2.91 |
Grrp1 |
glycine/arginine rich protein 1 |
469 |
0.63 |
chr6_143832506_143833713 | 2.90 |
Sox5 |
SRY (sex determining region Y)-box 5 |
113979 |
0.06 |
chr11_75165245_75169157 | 2.90 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr7_49522042_49523415 | 2.90 |
Nav2 |
neuron navigator 2 |
25464 |
0.21 |
chr3_84477728_84478854 | 2.89 |
Fhdc1 |
FH2 domain containing 1 |
691 |
0.74 |
chr6_135362982_135365483 | 2.89 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr16_95438855_95440188 | 2.89 |
Erg |
ETS transcription factor |
19724 |
0.24 |
chr14_75178051_75179727 | 2.88 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr10_111594457_111595800 | 2.88 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
855 |
0.55 |
chr17_28207522_28208953 | 2.87 |
Def6 |
differentially expressed in FDCP 6 |
353 |
0.78 |
chr18_61954762_61955556 | 2.86 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
2075 |
0.33 |
chr13_109686854_109687251 | 2.85 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
876 |
0.76 |
chr3_129331827_129332986 | 2.85 |
Enpep |
glutamyl aminopeptidase |
142 |
0.95 |
chr2_58160498_58161190 | 2.83 |
Cytip |
cytohesin 1 interacting protein |
187 |
0.94 |
chr4_155962283_155963451 | 2.83 |
C1qtnf12 |
C1q and tumor necrosis factor related 12 |
549 |
0.55 |
chr10_128179228_128179393 | 2.81 |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
987 |
0.32 |
chr13_53688729_53689284 | 2.80 |
Gm34278 |
predicted gene, 34278 |
11411 |
0.2 |
chr9_105520039_105521535 | 2.79 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr17_31657378_31657529 | 2.78 |
U2af1 |
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1 |
963 |
0.38 |
chr6_11593896_11594073 | 2.77 |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
313409 |
0.01 |
chr11_104581399_104582090 | 2.76 |
Myl4 |
myosin, light polypeptide 4 |
295 |
0.83 |
chrX_109095469_109096644 | 2.74 |
Sh3bgrl |
SH3-binding domain glutamic acid-rich protein like |
547 |
0.77 |
chr10_80016553_80017516 | 2.73 |
Arhgap45 |
Rho GTPase activating protein 45 |
118 |
0.91 |
chr3_68056570_68056803 | 2.72 |
Schip1 |
schwannomin interacting protein 1 |
8116 |
0.3 |
chr2_35333839_35333990 | 2.72 |
Stom |
stomatin |
3062 |
0.18 |
chr1_38766937_38768045 | 2.71 |
2610300A13Rik |
RIKEN cDNA 2610300A13 gene |
307 |
0.91 |
chr10_5594267_5594984 | 2.71 |
Myct1 |
myc target 1 |
850 |
0.67 |
chr1_52120178_52120386 | 2.71 |
Stat1 |
signal transducer and activator of transcription 1 |
658 |
0.59 |
chr4_132274460_132275262 | 2.70 |
Taf12 |
TATA-box binding protein associated factor 12 |
445 |
0.57 |
chr5_101703839_101704156 | 2.70 |
Gm42133 |
predicted gene, 42133 |
66 |
0.85 |
chr1_16687809_16688116 | 2.70 |
Ly96 |
lymphocyte antigen 96 |
89 |
0.96 |
chr2_119299920_119301063 | 2.69 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
11704 |
0.1 |
chrX_101418815_101419777 | 2.69 |
Zmym3 |
zinc finger, MYM-type 3 |
502 |
0.72 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.1 | 9.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.1 | 8.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.1 | 8.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.1 | 6.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 5.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 6.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.6 | 4.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.6 | 4.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 1.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.5 | 5.9 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.5 | 2.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.4 | 5.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.4 | 4.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 2.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.3 | 6.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 3.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.3 | 2.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.2 | 4.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.2 | 1.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.2 | 4.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
1.2 | 5.9 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.2 | 2.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.1 | 1.1 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.1 | 2.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 5.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.1 | 3.4 | GO:0061010 | gall bladder development(GO:0061010) |
1.1 | 2.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 3.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.1 | 4.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 3.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.1 | 4.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 4.2 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.0 | 3.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.0 | 3.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.0 | 2.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.0 | 3.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 2.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.0 | 2.9 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.9 | 2.8 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.9 | 3.7 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.9 | 4.6 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.9 | 2.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 4.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 2.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.9 | 2.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.9 | 4.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 2.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.8 | 3.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.8 | 5.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.8 | 2.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 3.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 2.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 3.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.8 | 3.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.8 | 2.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.8 | 2.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.8 | 4.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 3.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.8 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 1.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 0.8 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.8 | 2.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.7 | 4.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 1.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.7 | 2.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 2.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 1.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.7 | 2.2 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.7 | 3.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 3.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 5.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.7 | 3.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.7 | 0.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.7 | 3.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.7 | 2.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 4.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 8.4 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 3.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 2.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.7 | 2.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 3.5 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.7 | 8.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.7 | 1.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.7 | 2.7 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 2.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.7 | 2.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.7 | 2.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 1.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.7 | 1.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 2.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 6.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 2.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.7 | 3.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 2.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.6 | 0.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.6 | 1.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 1.3 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.6 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 6.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.6 | 2.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 1.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 1.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.6 | 4.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.6 | 3.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.6 | 1.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.6 | 1.9 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.6 | 1.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.6 | 3.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.6 | 3.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 1.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 1.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 2.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 1.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 3.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.6 | 9.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 6.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.6 | 1.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 2.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 4.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.6 | 1.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 1.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 1.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.6 | 3.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.6 | 3.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 2.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 1.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 2.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.6 | 1.8 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.6 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 2.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.6 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 5.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.6 | 3.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 2.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.6 | 0.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.6 | 1.1 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.6 | 3.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 4.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.6 | 3.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.6 | 7.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.6 | 2.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 2.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 3.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 1.1 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.6 | 3.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 1.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.6 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.5 | 2.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.5 | 1.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 2.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 0.5 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.5 | 2.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.5 | 2.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 1.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 1.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.5 | 2.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.5 | 2.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.5 | 3.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 2.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.5 | 2.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 2.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 1.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.5 | 1.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.5 | 1.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 0.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.5 | 5.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 4.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 4.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 1.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.5 | 2.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 2.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 4.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 1.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 4.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 2.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 1.0 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 2.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 1.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 4.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 2.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 3.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 1.5 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.5 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 3.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 4.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 1.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 1.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 4.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 4.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 0.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.5 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 1.0 | GO:1990414 | cellular response to camptothecin(GO:0072757) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.5 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 8.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 3.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.5 | 1.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.5 | 1.4 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 2.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 0.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 3.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 1.4 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 3.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 1.9 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.5 | 7.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.5 | 0.5 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.4 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.5 | 1.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.4 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.5 | 3.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.5 | 1.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.5 | 1.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 3.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 1.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 0.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 0.5 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.5 | 4.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 4.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 1.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 3.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.4 | 1.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.4 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 2.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 3.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 3.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 2.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 1.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 5.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 7.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 1.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 2.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 2.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.4 | 0.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 1.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.7 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.4 | 1.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 2.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 1.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 3.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 2.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 1.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 3.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 0.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 4.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 2.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 1.7 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 2.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 10.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 3.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.4 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.4 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.4 | 2.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 2.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 1.2 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.4 | 1.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.8 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 2.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 0.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 2.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 9.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 1.2 | GO:2000343 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 0.8 | GO:0061009 | intrahepatic bile duct development(GO:0035622) common bile duct development(GO:0061009) |
0.4 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 3.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 4.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 4.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.4 | 1.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.4 | 2.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.4 | 1.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 0.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.4 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
0.4 | 1.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 1.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 2.3 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.4 | 1.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 2.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 0.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.4 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 0.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 1.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.4 | 1.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 4.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.4 | 8.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 8.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.5 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.4 | 1.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.4 | 1.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 0.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 2.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 1.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 1.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 0.4 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 1.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.7 | GO:0051029 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.4 | 1.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 0.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.4 | 1.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 2.5 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.4 | 0.4 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.4 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 2.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 1.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 2.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 1.4 | GO:1903798 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 2.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 3.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 6.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.3 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.3 | 1.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 1.7 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 1.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 5.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 3.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 5.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 3.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.7 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.3 | 2.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 2.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 3.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.7 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) deoxyribonucleoside triphosphate catabolic process(GO:0009204) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.3 | 1.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 1.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 2.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 1.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 2.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 1.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 2.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 2.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 1.0 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 2.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.9 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.3 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.9 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.3 | 2.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 0.9 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 0.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.3 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 1.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 6.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 2.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 0.9 | GO:0006266 | DNA ligation(GO:0006266) |
0.3 | 1.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 2.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 2.4 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.3 | 1.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 3.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 3.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.3 | 1.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 5.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 2.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.3 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 1.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 1.4 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 2.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 0.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 3.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 7.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 1.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 4.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.6 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 2.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 2.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 2.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.6 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.3 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 3.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 1.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.6 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 0.3 | GO:0071025 | RNA surveillance(GO:0071025) |
0.3 | 2.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.7 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.3 | 1.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 1.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 2.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 10.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 3.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 9.2 | GO:0043038 | amino acid activation(GO:0043038) |
0.3 | 1.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 1.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.3 | GO:0090656 | t-circle formation(GO:0090656) positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 1.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 2.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.3 | 1.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 10.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 2.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 1.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 4.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.3 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 0.8 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 1.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 0.5 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 0.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 0.3 | GO:0003284 | septum primum development(GO:0003284) |
0.3 | 4.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 3.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.3 | 3.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 1.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 0.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.3 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.8 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 1.0 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 1.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 0.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.2 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.2 | 2.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 3.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 2.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.0 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.7 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 1.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 1.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.5 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 6.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.2 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 1.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 3.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.9 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 4.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 3.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 3.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 2.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 2.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 2.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 2.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 2.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 1.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 0.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 3.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 2.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 1.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.4 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.2 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 3.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 1.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 1.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 3.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 1.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.2 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.6 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 2.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 4.9 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.2 | 0.8 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 1.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.6 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 1.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 1.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 1.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 6.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 1.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 2.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 2.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 3.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.2 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 3.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.2 | 1.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.2 | 0.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 2.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.4 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.4 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 1.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 2.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 3.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 1.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 4.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.2 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.2 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 1.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 2.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.2 | 0.2 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.2 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 0.5 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.2 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 1.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.5 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 2.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 2.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.7 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.2 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 6.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 1.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 3.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 1.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 1.0 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.6 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 5.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.5 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.2 | 0.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 2.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.6 | GO:0019083 | viral transcription(GO:0019083) |
0.2 | 5.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 2.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.2 | 1.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.2 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 2.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 2.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 2.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.8 | GO:0019068 | virion assembly(GO:0019068) |
0.2 | 1.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.5 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.3 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.3 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 4.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.9 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 1.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 4.3 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 1.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 2.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.9 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 2.6 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 1.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0002866 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) type II hypersensitivity(GO:0002445) positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 3.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 1.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.9 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 1.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.6 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.1 | 1.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 2.0 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 2.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.4 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 5.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.8 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 1.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 3.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 0.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.3 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.1 | 1.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 2.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 1.1 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 1.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 2.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 5.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 2.6 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.8 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.9 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 1.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.8 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 5.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 2.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 2.0 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.4 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 6.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.5 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 1.1 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 3.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.4 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.2 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.1 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 2.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 7.3 | GO:0000423 | macromitophagy(GO:0000423) |
0.1 | 0.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.5 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 1.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.0 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 0.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 1.3 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 0.3 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.1 | 1.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.4 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
0.1 | 1.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 1.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.1 | GO:0051006 | regulation of lipoprotein lipase activity(GO:0051004) positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.8 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.2 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.1 | 0.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.1 | 0.9 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.1 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.7 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 2.5 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.8 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.4 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:1903201 | regulation of oxidative stress-induced cell death(GO:1903201) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 1.3 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.3 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 2.9 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 1.1 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.6 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0042701 | progesterone secretion(GO:0042701) |
0.0 | 1.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.0 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.7 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 1.3 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.1 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.2 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.0 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.5 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 4.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.0 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.0 | 2.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 1.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.0 | 0.0 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.0 | 0.3 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.4 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 1.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.3 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0051767 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.8 | 8.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.5 | 4.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.2 | 7.5 | GO:0042629 | mast cell granule(GO:0042629) |
1.1 | 4.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 4.3 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 6.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 6.2 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 3.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 4.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 2.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 5.4 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 2.5 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 4.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.8 | 0.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.8 | 3.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 2.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 3.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 5.3 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 2.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 1.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 3.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 3.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.6 | 9.3 | GO:0031430 | M band(GO:0031430) |
0.6 | 2.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 2.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 3.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 5.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 1.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 3.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 1.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 1.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 2.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 4.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 3.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 2.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 2.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 2.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 5.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 3.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 3.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 4.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 3.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 2.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 1.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 2.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 1.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 1.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 2.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 8.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 1.8 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 2.2 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 4.8 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 2.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 16.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 4.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 2.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 2.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 9.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 1.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 1.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 5.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 9.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 2.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 3.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 3.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 4.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 4.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 4.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 2.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 4.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 4.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 1.1 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 4.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 3.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 4.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 1.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 4.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 4.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 4.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 12.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 6.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 1.6 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 3.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 20.4 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.9 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 0.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 10.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 1.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 6.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 5.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 3.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 3.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 3.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 2.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 2.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 0.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 2.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 2.1 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 4.5 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 2.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 2.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 3.4 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.8 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 2.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 4.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 2.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.0 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 6.2 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 5.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 7.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 64.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 3.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 6.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 4.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 3.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 2.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 3.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 15.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 9.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 2.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 6.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 2.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 5.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 3.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 7.2 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 24.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 4.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 2.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 9.5 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 56.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 15.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 3.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 1.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 3.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 2.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 1.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 2.2 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 5.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.2 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 12.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.7 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 1.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 5.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 6.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 2.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 6.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 2.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 4.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 4.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 1.5 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 0.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 5.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 3.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 6.4 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.4 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 9.2 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 3.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 4.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 5.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 15.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 8.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 29.7 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 2.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 7.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 8.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 2.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 80.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 5.6 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 126.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 5.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 3.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 5.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 16.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 2.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 6.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 2.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 2.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.6 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 11.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.6 | 3.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.5 | 4.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.5 | 6.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.4 | 4.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.4 | 5.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.3 | 5.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.3 | 10.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.3 | 3.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.2 | 4.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.2 | 4.8 | GO:0031433 | telethonin binding(GO:0031433) |
1.1 | 4.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.1 | 4.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.1 | 1.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.1 | 3.2 | GO:0030172 | troponin C binding(GO:0030172) |
1.1 | 3.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.0 | 4.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.0 | 3.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 3.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.0 | 5.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 3.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 3.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 4.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.9 | 2.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.9 | 6.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 2.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 2.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.8 | 3.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 4.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 2.5 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.8 | 1.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.8 | 4.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 4.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 3.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 2.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 2.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 2.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 5.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 7.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 0.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 4.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 3.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 2.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.7 | 5.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 2.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.6 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 3.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 4.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 2.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 3.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 1.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 1.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 3.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.6 | 1.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.6 | 4.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 1.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 2.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 2.4 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 1.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 1.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 5.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 1.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 4.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.6 | 1.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 2.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 2.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 6.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.6 | 1.7 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 8.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 5.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 2.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 7.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.0 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 1.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.5 | 1.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 2.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 3.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 2.9 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 1.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 1.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 3.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 5.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 3.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 3.1 | GO:0097617 | annealing activity(GO:0097617) |
0.4 | 7.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 2.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 4.8 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 1.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 4.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 3.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 6.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 4.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 2.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 2.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 5.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 2.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 1.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 2.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.2 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 2.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 2.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.4 | 2.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 1.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 1.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 8.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 4.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 3.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 2.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 2.6 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 1.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 2.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.9 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 6.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 4.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 3.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 2.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 5.8 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 6.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 3.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 5.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 3.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 5.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 1.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 2.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 3.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 1.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 2.9 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 2.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 8.2 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 6.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 1.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 2.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 2.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 2.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.2 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.3 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 2.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 2.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 5.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 2.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 4.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 8.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 6.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 1.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 3.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 3.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 1.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 0.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 2.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 5.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 3.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 4.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 2.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 5.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 4.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 5.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 3.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 6.8 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.3 | 1.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 4.7 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 1.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 7.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 2.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 4.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 0.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 8.0 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 1.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 5.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 2.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 3.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 5.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 40.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 6.9 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 2.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.5 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 3.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 2.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 17.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 6.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 2.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 4.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 6.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 2.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 2.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.7 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 2.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 2.4 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.2 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 3.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 1.9 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 10.7 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.7 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 4.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.6 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 34.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 4.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.2 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 6.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 4.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 3.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 6.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 33.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 4.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 4.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.7 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 4.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 2.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 14.8 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 2.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 5.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 2.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 7.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 5.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 2.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 4.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 6.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 14.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 6.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 2.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 4.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.5 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 2.4 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 1.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 3.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 5.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 3.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 6.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 13.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 1.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.5 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 3.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.4 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 2.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.6 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 2.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 2.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 2.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 2.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 3.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 2.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 7.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 2.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 8.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 2.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 2.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 30.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.5 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.0 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.4 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 6.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 4.9 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.4 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 1.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.2 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 1.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:1901618 | organic hydroxy compound transmembrane transporter activity(GO:1901618) |
0.0 | 0.7 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 1.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 1.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 9.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 1.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 25.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 2.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 6.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 11.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 15.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 3.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 2.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 17.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 14.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 2.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 3.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 5.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 9.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 1.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 7.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 19.1 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 9.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 4.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 2.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 8.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 4.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 8.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 7.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 12.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 5.5 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 3.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 7.0 | PID ATM PATHWAY | ATM pathway |
0.3 | 16.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 5.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 9.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 1.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 6.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 1.2 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 3.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 11.1 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 8.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 2.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 6.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 2.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 4.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 3.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 7.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 6.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 4.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 6.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 4.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 4.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 12.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 12.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.8 | 11.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 11.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 1.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.6 | 7.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 6.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 8.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 2.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 10.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 12.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 6.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 6.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 42.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 4.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 6.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 3.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 6.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 5.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 3.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 8.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 2.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 4.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 3.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 6.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 39.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 3.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 26.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 2.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 1.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.4 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 7.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.3 | 5.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 4.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 2.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 4.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 2.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 5.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 13.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 1.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 3.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 6.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 4.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 3.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 2.4 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 1.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 7.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 15.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 17.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 7.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 4.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 5.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 1.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 6.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 1.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 4.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 2.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 6.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 2.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 26.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 6.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 2.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 18.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 4.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 1.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 9.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 5.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 5.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 8.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 7.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 4.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 5.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 6.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 4.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 3.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 12.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 6.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 9.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.2 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 2.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 5.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 7.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 0.7 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 5.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 4.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 2.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 20.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.9 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 3.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.5 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 3.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 5.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.7 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 1.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |